US Army biodefense strategy says AI and biotechnology are lowering the barrier to engineering biological weapons

US Army · Strategy

Read the source (opens in a new tab)
What happened
The US Army published its 2026 Army Biodefense Strategy, which sets goals to 2035 and opens with a foreword from the Secretary of the Army.
Key points
  • The foreword says "advanced biotechnology and artificial intelligence are dramatically lowering the barrier to engineering biological weapons" and calls this "a strategic threat."
  • The strategy says advances in biotechnology, synthetic biology and AI "lower the barrier for developing novel biological weapons," for state and non-state actors alike.
  • It makes biodefense "a core warfighting imperative" Army-wide, with five lines of effort so forces can "deploy, fight, and win decisively in a bio-contested environment" by 2035.
  • It directs the Army to use AI and machine learning to analyze biosurveillance data, identify emerging threats and detect adversary misinformation about biological threats.
Evidence
The Army's own strategy document. It sets goals and tasks and says it will be carried out through "a detailed, separate implementation plan."

See it in the latest record